Which Hedge Funds Own CPRX — Catalyst Pharmaceuticals Inc.

15 of the hedge funds we track hold CPRX, worth $169.6M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 4 opened a new position, 3 added, 7 trimmed, 3 exited.

11 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at CPRX · All tracked funds